Abstract:Purpose: Magnetic resonance imaging (MRI) is a promising technique for detecting amyloid beta (A beta) deposits in Alzheimer's disease (AD). Contrast agents can reduce the scanning time and provide specific images to identify various structures. This study aimed to develop an ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle coupled with a functional protein as a targeted MRI contrast agent to detect A beta deposits. Methods: The targeted MRI contrast agent USPIO nanoparticle was coupled with A beta((16-20)) (KLVFF) and HIV-1 trans-activating transcriptor-protein transduction domain (Tat-PTD) to produce the Tat-PTD-USPIO-A beta((16-20)) structure to better penetrate the blood-brain barrier (BBB). In vitro studies were conducted to measure the coupling efficiency, including bicinchoninic acid protein assays, potassium ferrocyanide staining of cardiac microvascular endothelial cells, 1.5T MRI, and toxicity assessments. The contrast agent was injected into five transgenic mice and five age-matched wild-type mice for MRI and histological studies. The targeted agent was diluted, and all mice were scanned with a 7.0 Tesla MRI-scanner. The brain tissues were processed as frozen sections for Thioflavin-S staining to detect A beta. Results: The coupling efficiency reached 97.75%. The developed MRI contrast agent successfully passed through biological membranes, bound to AB deposits, and decreased the MRI signal of tissue in vitro and in vivo. Compared with A beta((16-20)) or A beta((3-40)) alone, there was no significant toxicity of Tat-PTD or A beta((16-20)) when coupled with USPIO nanoparticles. Conclusion: Our novel MRI contrast agent USPIO nanoparticle coupled with functional protein can pass through biological membranes in vitro and visualize A beta deposits in AD animal models by MRI.

Noninvasive Visualization of Amyloid-Beta Deposits in Alzheimer's Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent

Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice

AIE-based Fluorescent Micro-Optical Sectioning Tomography for Automatic 3D Mapping of Β-Amyloid Plaques in Tg Mouse Whole Brain

Visualizing Aβ Deposits in Live Young AD Model Mice with a Simple Red/near-Infrared-fluorescent AIEgen

Fluorescent Imaging of Amyloid-β Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for in vivo Imaging.

In vivo evaluation of novel near-infrared fluorescence probe THK565 for imaging amyloid β and tau protein deposits in Alzheimer‘s mouse models

Amyloid Plaque Imaging with a Targeted MRI Contrast Agent in a Transgenic Mouse Model of Alzheimer’s Disease

Long-Term Repeatable In Vivo Monitoring of Amyloid-β Plaques and Vessels in Alzheimer's Disease Mouse Model with Combined TPEF/CARS Microscopy

High-fidelity imaging of amyloid-beta deposits with an ultrasensitive fluorescent probe facilitates the early diagnosis and treatment of Alzheimer's Disease

Label-free Brainwide Visualization of Senile Plaque Using Cryo-Micro-optical Sectioning Tomography

Development of Novel Near-Infrared GFP Chromophore-Based Fluorescent Probes for Imaging of Amyloid-Β Plaque and Viscosity

Smart Near-Infrared Fluorescence Probes with Donor–Acceptor Structure for in Vivo Detection of Β-Amyloid Deposits

A Near-infrared Fluorescence and Positron Emission Tomography Bimodal Probe for in Vivo Imaging of Amyloid-β Species.

A Near-infrared Fluorescence and Positron Emission Tomography Bimodal Probe for I n Vivo I maging of Amyloid-β Species

Label free visualization of amyloid plaques in Alzheimer's disease with polarization-sensitive photoacoustic Mueller matrix tomography

In Vivo Near-Infrared And Cerenkov Luminescence Imaging Of Amyloid-Beta Deposits In The Brain: A Fluorinated Small Molecule Used For Dual-Modality Imaging

3D dynamic tracking Aβ plaques in live brains using vinyl-bridged dyes with two-photon excitation/NIR emission and large Stokes shifts

Preparation of near-infrared AIEgen-active fluorescent probes for mapping amyloid-β plaques in brain tissues and living mice

Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer’s Disease

Advances in development of fluorescent probes for detecting amyloid-β aggregates

Near-infrared Fluorescent Probes for Imaging of Amyloid Plaques in Alzheimer׳s Disease.